Citations (97)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yi Lu, Jiaxi Yu, Qiuping Dong, Yan Du & Zheng Liang. (2022) DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis. International Journal of General Medicine 15, pages 6127-6143.
Read now
Read now
Neema Negi, Shesh Prakash Maurya, Ravinder Singh & Bimal Kumar Das. (2022) An update on host immunity correlates and prospects of re-infection in COVID-19. International Reviews of Immunology 41:4, pages 367-392.
Read now
Read now
Joachim Stoltenborg Granhøj, Agnete Witness Præst Jensen, Mario Presti, Özcan Met, Inge Marie Svane & Marco Donia. (2022) Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions. Expert Opinion on Biological Therapy 22:5, pages 627-641.
Read now
Read now
Vindya Nilakshi Wijesinghe, Isra Ahmad Farouk, Nur Zawanah Zabidi, Ashwini Puniyamurti, Wee Sim Choo & Sunil Kumar Lal. (2021) Current vaccine approaches and emerging strategies against herpes simplex virus (HSV). Expert Review of Vaccines 20:9, pages 1077-1096.
Read now
Read now
Yasser Tabana, Tae Chul Moon, Arno Siraki, Shokrollah Elahi & Khaled Barakat. (2021) Reversing T-cell exhaustion in immunotherapy: a review on current approaches and limitations. Expert Opinion on Therapeutic Targets 25:5, pages 347-363.
Read now
Read now
Articles from other publishers (92)
Shishuo Sun, Heng Xu, Wanxin Zhao, Qihong Li, Yifan Yuan, Guopeng Zhang, Shuyu Li, Bixi Wang, Wei Zhang, Xiaoge Gao, Junnian Zheng & Qing Zhang. (2024) PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca2+ flux. Cancer Letters 581, pages 216511.
Crossref
Crossref
Enar Jumaniyazova, Anastasiya Lokhonina, Dzhuliia Dzhalilova, Anna Kosyreva & Timur Fatkhudinov. (2023) Immune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas. Cancers 15:24, pages 5760.
Crossref
Crossref
Kumaravel Mohankumar, Gus Wright, Subhashree Kumaravel, Rupesh Shrestha, Lei Zhang, Maen Abdelrahim, Robert S. Chapkin & Stephen Safe. (2023) Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion. Cancer Immunology, Immunotherapy 72:12, pages 3985-3999.
Crossref
Crossref
Choong-Hyun Koh, Suyoung Lee, Minkyeong Kwak, Byung-Seok Kim & Yeonseok Chung. (2023) CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential. Experimental & Molecular Medicine 55:11, pages 2287-2299.
Crossref
Crossref
Lili Liu, Yateng Li, Yu Song, Zhen Sun, Wenjing Li, Bin Li, Yongjie Wang, Haibo Wang & Bin Wang. (2023) One-step shotgun approach for antigenic specific pMHCs capture stimulated CD8+ T cell activation and proliferation. Cellular Immunology 393-394, pages 104784.
Crossref
Crossref
Tang ansu Zhang, Qian Zhang, Jun Zhang, Rong Zhao, Rui Shi, Sitian Wei, Shuangge Liu, Qi Zhang & Hongbo Wang. (2023) Identification of the role of endoplasmic reticulum stress genes in endometrial cancer and their association with tumor immunity. BMC Medical Genomics 16:1.
Crossref
Crossref
Seiji Natsuki, Hiroaki Tanaka, Masaki Nishiyama, Sota Deguchi, Yuichiro Miki, Mami Yoshii, Tatsuro Tamura, Takahiro Toyokawa, Shigeru Lee & Kiyoshi Maeda. (2023) Significance of CD103+ tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer. BMC Cancer 23:1.
Crossref
Crossref
Jutatip Panaampon, Yubin Zhou & Charupong Saengboonmee. (2023) Metformin as a booster of cancer immunotherapy. International Immunopharmacology 121, pages 110528.
Crossref
Crossref
Ishita Gupta, Ola Hussein, Konduru Seetharama Sastry, Salim Bougarn, Neha Gopinath, Evonne Chin-Smith, Yashi Sinha, Hesham Mohamed Korashy & Cristina Maccalli. (2023) Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications. Advances in Cancer Biology - Metastasis, pages 100107.
Crossref
Crossref
Mei Sakuma, Kosaku Mimura, Shotaro Nakajima, Akinao Kaneta, Tomohiro Kikuchi, Azuma Nirei, Takeshi Tada, Hiroyuki Hanayama, Hirokazu Okayama, Wataru Sakamoto, Motonobu Saito, Tomoyuki Momma, Zenichiro Saze & Koji Kono. (2023) A Potential Biomarker of Dynamic Change in Peripheral CD45RA−CD27+CD127+ Central Memory T Cells for Anti-PD-1 Therapy in Patients with Esophageal Squamous Cell Carcinoma. Cancers 15:14, pages 3641.
Crossref
Crossref
Kanako Shimizu, Shogo Ueda, Masami Kawamura, Honoka Aoshima, Mikiko Satoh, Jun Nakabayashi & Shin-ichiro Fujii. (2023)
Combination of cancer vaccine with CD122-biased IL-2/anti-IL-2 Ab complex shapes the stem-like effector NK and CD8
+
T cells against tumor
. Journal for ImmunoTherapy of Cancer 11:7, pages e006409.
Crossref
Crossref
Andrea Botticelli, Alessio Cirillo, Giulia Pomati, Enrico Cortesi, Ernesto Rossi, Giovanni Schinzari, Giampaolo Tortora, Silverio Tomao, Giulia Fiscon, Lorenzo Farina, Simone Scagnoli, Simona Pisegna, Fabio Ciurluini, Antonella Chiavassa, Sasan Amirhassankhani, Fulvia Ceccarelli, Fabrizio Conti, Alessandra Di Filippo, Ilaria Grazia Zizzari, Chiara Napoletano, Aurelia Rughetti, Marianna Nuti, Silvia Mezi & Paolo Marchetti. (2023) Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach. Cancer Immunology, Immunotherapy 72:7, pages 2217-2231.
Crossref
Crossref
Elizabeth M. Muhowski & Laura M. Rogers. (2023) Dual TCR-Expressing T Cells in Cancer: How Single-Cell Technologies Enable New Investigation. ImmunoHorizons 7:5, pages 299-306.
Crossref
Crossref
Martina S. Lutz, Latifa Zekri, Laura Weßling, Susanne Berchtold, Jonas S. Heitmann, Ulrich M. Lauer, Gundram Jung & Helmut R. Salih. (2023) IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer. Frontiers in Immunology 14.
Crossref
Crossref
Latifa Zekri, Martina Lutz, Nisha Prakash, Timo Manz, Boris Klimovich, Stefanie Mueller, Sebastian Hoerner, Ilona Hagelstein, Monika Engel, Anna Chashchina, Martin Pfluegler, Jonas S. Heitmann, Gundram Jung & Helmut R. Salih. (2023) An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers. Molecular Therapy 31:4, pages 1033-1045.
Crossref
Crossref
Fátima Ferragut, Paula B. Alcaraz, Paula Beati, Magali C. Girard, Micaela S. Ossowski, Raúl Chadi, Marisa Fernández, Yolanda Hernández-Vásquez, Gonzalo R. Acevedo & Karina A. Gómez. (2023) Expression of Inhibitory Receptors TIGIT, TIM-3, and LAG-3 on CD4+ T Cells from Patients with Different Clinical Forms of Chronic Chagas Disease. The Journal of Immunology 210:5, pages 568-579.
Crossref
Crossref
Saraí G. De Leon-Rodríguez, Cristina Aguilar-Flores, Julián A. Gajón, Alejandra Mantilla, Raquel Gerson-Cwilich, José Fabián Martínez-Herrera, Benigno E. Rodríguez-Soto, Claudia T. Gutiérrez-Quiroz, Vadim Pérez-Koldenkova, Samira Muñoz-Cruz, Laura C. Bonifaz & Ezequiel M. Fuentes-Pananá. (2023) Acral Melanoma Is Infiltrated with cDC1s and Functional Exhausted CD8 T Cells Similar to the Cutaneous Melanoma of Sun-Exposed Skin. International Journal of Molecular Sciences 24:5, pages 4786.
Crossref
Crossref
Muhammad Babar Khawar, Ali Afzal, Muddasir Hassan Abbasi, Nadeem Sheikh & Haibo Sun. (2023) Nano-immunoengineering of CAR-T cell therapy against tumor microenvironment: The way forward in combating cancer. OpenNano 10, pages 100124.
Crossref
Crossref
Xiuxiu Zhu, Wuling Li, Jiadong Gao, Junjie Shen, Yanmin Xu, Chengcheng Zhang & Cheng Qian. (2023) RUNX3 improves CAR-T cell phenotype and reduces cytokine release while maintaining CAR-T function. Medical Oncology 40:3.
Crossref
Crossref
Bogang Wu, Leilei Qi, Huai-Chin Chiang, Haihui Pan, Xiaowen Zhang, Alexandra Greenbaum, Elizabeth Stark, Li-Ju Wang, Yidong Chen, Bassem R. Haddad, Dionyssia Clagett, Claudine Isaacs, Richard Elledge, Anelia Horvath, Yanfen Hu & Rong Li. (2023)
BRCA1 deficiency in mature CD8
+
T lymphocytes impairs antitumor immunity
. Journal for ImmunoTherapy of Cancer 11:2, pages e005852.
Crossref
Crossref
Luling Wang & Xing Liu. (2023) An oxidative stress-related signature for predicting the prognosis of liver cancer. Frontiers in Genetics 13.
Crossref
Crossref
Zichao Zhang, Zhihui Wang, Yumeng Liu, Li Zhao & Weihua Fu. (2023) Stromal Interaction Molecule 1 (STIM1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Solid Tumors. Journal of Environmental Pathology, Toxicology and Oncology 42:2, pages 11-30.
Crossref
Crossref
Yohei Nose, Takuro Saito, Kei Yamamoto, Kotaro Yamashita, Koji Tanaka, Kazuyoshi Yamamoto, Tomoki Makino, Tsuyoshi Takahashi, Atsunari Kawashima, Miya Haruna, Michinari Hirata, Azumi Ueyama, Kota Iwahori, Taroh Satoh, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki & Hisashi Wada. (2022) The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer. Cancer Immunology, Immunotherapy 72:1, pages 169-181.
Crossref
Crossref
Mariana Malvincini & Laura Alaniz. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
22
.
Miriana d’Alessandro, Edoardo Conticini, Laura Bergantini, Fabrizio Mezzasalma, Paolo Cameli, Stefano Baglioni, Martina Armati, Marta Abbritti & Elena Bargagli. (2022) PD1, CTLA4 and TIGIT Expression on T and NK Cells in Granulomatous Diseases: Sarcoidosis and ANCA-Associated Vasculitis. International Journal of Molecular Sciences 24:1, pages 256.
Crossref
Crossref
Malgorzata Kloc, Jacek Z. Kubiak, Robert Zdanowski & Rafik M. Ghobrial. (2022) Memory Macrophages. International Journal of Molecular Sciences 24:1, pages 38.
Crossref
Crossref
Maiko Machida, Chika Yamazaki, Nao Kouda, Yousei Hanai, Hideki Sato, Ainari Konda, Yuka Yamagata, Tatsuya Itho & Haruhiko Aisaka. (2022) A case report involving suppressed nuclear receptor transcription factors 4a1 and Stevens-Johnson syndrome induced by a single dose of pembrolizumab and successfully treated with early steroid administration, resulting in complete remission of stage III lung cancer. Journal of Pharmaceutical Health Care and Sciences 8:1.
Crossref
Crossref
Kazumi Okamura, Satoshi Nagayama, Tomohiro Tate, Hiu Ting Chan, Kazuma Kiyotani & Yusuke Nakamura. (2022) Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy. Journal of Translational Medicine 20:1.
Crossref
Crossref
Dandan Wang, Wenxing Gu, Weiliang Chen, Jin Zhou, Le Yu, Byung Kook Kim, Xuenong Zhang & Jong Seung Kim. (2022) Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy. Coordination Chemistry Reviews 472, pages 214788.
Crossref
Crossref
Xingcheng Yang, Jia Wei & Jianfeng Zhou. (2022) Overcoming resistance to anti‐CD19 CAR T‐cell therapy in B‐cell malignancies. Hematological Oncology 40:5, pages 821-834.
Crossref
Crossref
Yue Liu, Lingna An, Ruihao Huang, Jingkang Xiong, Haoyu Yang, Xiaoqi Wang & Xi Zhang. (2022) Strategies to enhance CAR-T persistence. Biomarker Research 10:1.
Crossref
Crossref
Fang-Cheng Jiang, Jia-Yuan Luo, Yi-Wu Dang, Hui-Ping Lu, Dong-Ming Li, Zhi-Guang Huang, Yu-Lu Tang, Ye-Ying Fang, Yu-Xing Tang, Ya-Si Su, Wen-Bin Dai, Shang-Ling Pan, Zhen-Bo Feng, Gang Chen & Juan He. (2022) Downregulation of zinc finger protein 71 in laryngeal squamous cell carcinoma tissues and its potential molecular mechanism and clinical significance: a study based on immunohistochemistry staining and data mining. World Journal of Surgical Oncology 20:1.
Crossref
Crossref
Tira J. Tan, W. X. Gladys Ang, Who-Whong Wang, Hui-Shan Chong, Sze Huey Tan, Rachael Cheong, John Whay-Kuang Chia, Nicholas L. Syn, Wai Ho Shuen, Rebecca Ba, Nivashini Kaliaperumal, Bijin Au, Richard Hopkins, Xinhua Li, Aaron C. Tan, Amanda O. L. Seet, John E. Connolly, Thaschawee Arkachaisri, Valerie Chew, Ahmad bin Mohamed Lajam, Dianyan Guo, Marvin Z. W. Chew, Martin Wasser, Pavanish Kumar, Salvatore Albani & Han Chong Toh. (2022) A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma. Nature Communications 13:1.
Crossref
Crossref
Xuepei Cai, Haokun Li, Manyi Wang, Edward Chu, Ning Wei, Jiayu Lin, Yun Hu, Jingtao Dai, Aijie Chen, Hua Zheng, Qianbing Zhang, Yuxia Zhong, Ruoshui Chang, Sha Wu, Yaomu Xiao & Chufeng Liu. (2022) mTOR participates in the formation, maintenance, and function of memory CD8+T cells regulated by glycometabolism. Biochemical Pharmacology 204, pages 115197.
Crossref
Crossref
Zhanyan Gao, Yang Feng, Jinhua Xu & Jun Liang. (2022) T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Muthuganesh Muthuvel, Harshita Srinivasan, Leena Louis & Sunil Martin. (2022) Engineering off-the-shelf universal CAR T cells: A silver lining in the cloud. Cytokine 156, pages 155920.
Crossref
Crossref
Adam Klocperk, David Friedmann, Alexandra Emilia Schlaak, Susanne Unger, Zuzana Parackova, Sigune Goldacker, Anna Sediva, Bertram Bengsch & Klaus Warnatz. (2022) Distinct CD8 T Cell Populations with Differential Exhaustion Profiles Associate with Secondary Complications in Common Variable Immunodeficiency. Journal of Clinical Immunology 42:6, pages 1254-1269.
Crossref
Crossref
Dian-Dian Liu, Wei-Cong Hong, Kun-Yin Qiu, Xin-Yu Li, Yong Liu, Li-Wen Zhu, Wei-Xin Lai, Han- Chen, Hua-Qing Yang, Lu-Hong Xu & Jian-Pei Fang. (2022) Umbilical cord blood: A promising source for allogeneic CAR-T cells. Frontiers in Oncology 12.
Crossref
Crossref
Hamidreza Hassanian, Zahra Asadzadeh, Amir Baghbanzadeh, Afshin Derakhshani, Antoine Dufour, Nazanin Rostami Khosroshahi, Souzan Najafi, Oronzo Brunetti, Nicola Silvestris & Behzad Baradaran. (2022) The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment. Frontiers in Immunology 13.
Crossref
Crossref
Thomas Yul Avery, Natalie Köhler, Robert Zeiser, Tilman Brummer & Dietrich Alexander Ruess. (2022) Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation. Frontiers in Oncology 12.
Crossref
Crossref
Jiajia Yuan, Xingwang Zhao, Yanyan Li, Qian Yao, Lei Jiang, Xujiao Feng, Lin Shen, Yilin Li & Yang Chen. (2022) The Association between Blood Indexes and Immune Cell Concentrations in the Primary Tumor Microenvironment Predicting Survival of Immunotherapy in Gastric Cancer. Cancers 14:15, pages 3608.
Crossref
Crossref
Zhigang Yi, Tao Ma, Jia Liu, Wenting Tie, Yanhong Li, Jun Bai, Lijuan Li & Liansheng Zhang. (2022) The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma. Frontiers in Immunology 13.
Crossref
Crossref
Evelyn P. Murphy & Daniel Crean. (2022) NR4A1-3 nuclear receptor activity and immune cell dysregulation in rheumatic diseases. Frontiers in Medicine 9.
Crossref
Crossref
Blandine Caël, Jeanne Galaine, Isabelle Bardey, Chrystel Marton, Maxime Fredon, Sabeha Biichle, Margaux Poussard, Yann Godet, Fanny Angelot-Delettre, Christophe Barisien, Christophe Bésiers, Olivier Adotevi, Fabienne Pouthier, Francine Garnache-Ottou & Elodie Bôle-Richard. (2022) Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells. Cancers 14:13, pages 3168.
Crossref
Crossref
Yansha Sun, Yiwei Dong, Ruixin Sun, Yifan Liu, Yi Wang, Hong Luo, Bizhi Shi, Hua Jiang & Zonghai Li. (2022) Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors. Molecular Therapy - Oncolytics 25, pages 160-173.
Crossref
Crossref
Jinghang Xie, Fadi El Rami, Kaixiang Zhou, Federico Simonetta, Zixin Chen, Xianchuang Zheng, Min Chen, Preethi B. Balakrishnan, Sheng-Yao Dai, Surya Murty, Israt S. Alam, Jeanette Baker, Robert S. Negrin, Sanjiv S. Gambhir & Jianghong Rao. (2022) Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade Therapies. ACS Central Science 8:5, pages 590-602.
Crossref
Crossref
Sara Franzi, Giovanni Mattioni, Erika Rijavec, Giorgio Alberto Croci & Davide Tosi. (2022) Neoadjuvant Chemo-Immunotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Review of the Literature. Journal of Clinical Medicine 11:9, pages 2629.
Crossref
Crossref
Gina López-Cantillo, Claudia Urueña, Bernardo Armando Camacho & Cesar Ramírez-Segura. (2022) CAR-T Cell Performance: How to Improve Their Persistence?. Frontiers in Immunology 13.
Crossref
Crossref
Bogang Wu, Xiaowen Zhang, Huai-Chin Chiang, Haihui Pan, Bin Yuan, Payal Mitra, Leilei Qi, Hayk Simonyan, Colin N. Young, Eric Yvon, Yanfen Hu, Nu Zhang & Rong Li. (2022) RNA polymerase II pausing factor NELF in CD8+ T cells promotes antitumor immunity. Nature Communications 13:1.
Crossref
Crossref
Lin Zhao, Yuanyuan Liu, Simiao Zhang, Lingyu Wei, Hongbing Cheng, Jinsheng Wang & Jia Wang. (2022) Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer. Cell Death & Disease 13:4.
Crossref
Crossref
Linjun Liang, Hongfa Xu, Qichao Dong, Lige Qiu, Ligong Lu, Qing Yang, Wei Zhao & Yong Li. (2022) WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Keywan Mortezaee & Jamal Majidpoor. (2022) CD8+ T Cells in SARS-CoV-2 Induced Disease and Cancer—Clinical Perspectives. Frontiers in Immunology 13.
Crossref
Crossref
Jing Ye, Yujie Jia, Israth Jahan Tuhin, Jingwen Tan, Masuma Akter Monty, Nan Xu, Liqing Kang, Minghao Li, Xiaoyan Lou, Meixia Zhou, Xiaoyan Fang, Jiaqi Shao, Hongjia Zhu, Zhiqiang Yan & Lei Yu. (2022) Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody. Molecular Therapy - Oncolytics 24, pages 719-728.
Crossref
Crossref
Igor Bryukhovetskiy. (2022) Cell‑based immunotherapy of glioblastoma multiforme (Review). Oncology Letters 23:4.
Crossref
Crossref
Xin Lai, Christine Keller, Guido Santos, Niels Schaft, Jan Dörrie & Julio Vera. (2022) Multi-Level Computational Modeling of Anti-Cancer Dendritic Cell Vaccination Utilized to Select Molecular Targets for Therapy Optimization. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Noel E. Donlon, Maria Davern, Andrew D. Sheppard, Fiona O’Connell, Margaret R. Dunne, Conall Hayes, Eimear Mylod, Sinead Ramjit, Hugo Temperley, Michael Mac Lean, Gillian Cotter, Anshul Bhardwaj, Christine Butler, Melissa J. Conroy, Jacintha O’Sullivan, Narayanasamy Ravi, Claire L. Donohoe, John V. Reynolds & Joanne Lysaght. (2022) The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint Inhibition. Frontiers in Immunology 13.
Crossref
Crossref
Teruaki Hagiwara, Takamasa Numano, Tomomi Hara, Taiki Sugiyama, Yukinori Mera, Seiko Tamano & Hiroto Miyata. (2022) Chemical-induced lung tumor in Tg-rasH2 mice: a novel mouse tumor model to assess immune checkpoint inhibitors combined with a chemotherapy drug. Journal of Toxicologic Pathology 35:4, pages 321-331.
Crossref
Crossref
Wanying Zeng & Pumin Zhang. (2022) Resistance and recurrence of malignancies after CAR-T cell therapy. Experimental Cell Research 410:2, pages 112971.
Crossref
Crossref
Zheng-zheng Zhang, Tian Wang, Xiao-feng Wang, Yu-qing Zhang, Shu-xia Song & Cui-qing Ma. (2022) Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies. Pharmacological Research 175, pages 106036.
Crossref
Crossref
Jian Zhang, Yuhui Peng, Yan He, Yan Xiao, Qinrong Wang, Yan Zhao, Tin Zhang, Changxue Wu, Yuan Xie, Jianjiang Zhou, Wenfeng Yu, Deqin Lu, Hua Bai, Tenxiang Chen, Penxiang Guo & Qifang Zhang. (2022) GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868:1, pages 166268.
Crossref
Crossref
Changsheng Zhou, Qianqian Liu, Yi Xiang, Xin Gou & Wengang Li. (2021) Role of the tumor immune microenvironment in tumor immunotherapy (Review). Oncology Letters 23:2.
Crossref
Crossref
Jack D. Chan, Junyun Lai, Clare Y. Slaney, Axel Kallies, Paul A. Beavis & Phillip K. Darcy. (2021) Cellular networks controlling T cell persistence in adoptive cell therapy. Nature Reviews Immunology 21:12, pages 769-784.
Crossref
Crossref
Adam Walter, Rodney P. Rocconi, Bradley J. Monk, Thomas J. Herzog, Luisa Manning, Ernest Bognar, Gladice Wallraven, Phylicia Aaron, Staci Horvath, Min Tang, Laura Stanbery, Robert L. Coleman & John Nemunaitis. (2021) Gemogenovatucel-T (Vigil) maintenance immunotherapy: 3-year survival benefit in homologous recombination proficient (HRP) ovarian cancer. Gynecologic Oncology 163:3, pages 459-464.
Crossref
Crossref
Fangshi Xu, Yibing Guan, Li Xue, Peng Zhang, Mingrui Li, Mei Gao & Tie Chong. (2021) The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi‐omics study. Cancer Medicine 10:24, pages 9078-9096.
Crossref
Crossref
Stephen Safe, Rupesh ShresthaKumaravel Mohankumar. (2021) Orphan nuclear receptor 4A1 (NR4A1) and novel ligands. Essays in Biochemistry 65:6, pages 877-886.
Crossref
Crossref
Makoto Ando, Taisuke Kondo, Wataru Tomisato, Minako Ito, Shigeyuki Shichino, Tanakorn Srirat, Setsuko Mise-Omata, Kensuke Nakagawara & Akihiko Yoshimura. (2021) Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Memory–Like CAR T Cells By Resting Them in the Presence of CXCL12 and the NOTCH Ligand. Cancer Research Communications 1:1, pages 41-55.
Crossref
Crossref
Violena Pietrobon, Lauren Anne Todd, Anghsumala Goswami, Ofir Stefanson, Zhifen Yang & Francesco Marincola. (2021) Improving CAR T-Cell Persistence. International Journal of Molecular Sciences 22:19, pages 10828.
Crossref
Crossref
Ali Zahedi-Amiri, Kyle Malone, Shawn T. Beug, Tommy Alain & Behzad Yeganeh. (2021) Autophagy in Tumor Immunity and Viral-Based Immunotherapeutic Approaches in Cancer. Cells 10:10, pages 2672.
Crossref
Crossref
Yujie Li, Dengqiang Wu, Xuejia Yang & Sufang Zhou. (2021) Immunotherapeutic Potential of T Memory Stem Cells. Frontiers in Oncology 11.
Crossref
Crossref
Mohamad Hamieh, Jean-François Chatillon, Estelle Dupel, Florence Bayeux, Emilie Fauquembergue, Pauline Maby, Aurelie Drouet, Anne-Bénédicte Duval-Modeste, Sahil Adriouch, Olivier Boyer & Jean-Baptiste Latouche. (2021) Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Julian J. Freen‐van Heeren. (2021) Post‐transcriptional control of T‐cell cytokine production: Implications for cancer therapy. Immunology 164:1, pages 57-72.
Crossref
Crossref
Luana Madalena Sousa, Jani Sofia Almeida, Tânia Fortes-Andrade, Manuel Santos-Rosa, Paulo Freitas-Tavares, José Manuel Casanova & Paulo Rodrigues-Santos. (2021) Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy. Cancers 13:15, pages 3885.
Crossref
Crossref
Gideon WolfNevil J. Singh. (2021) Modular Approaches to Understand the Immunobiology of Human Immunodeficiency Virus Latency. Viral Immunology 34:6, pages 365-375.
Crossref
Crossref
Terufumi Kubo, Tomoyo Shinkawa, Yasuhiro Kikuchi, Kenji Murata, Takayuki Kanaseki, Tomohide Tsukahara, Yoshihiko Hirohashi & Toshihiko Torigoe. (2021) Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy. Frontiers in Oncology 11.
Crossref
Crossref
Yao Jin, Aili Tan, Jia Feng, Zexi Xu, Peiwei Wang, Peng Ruan, Ruijun Luo, Yiming Weng & Min Peng. (2021) Prognostic Impact of Memory CD8(+) T Cells on Immunotherapy in Human Cancers: A Systematic Review and Meta-Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Akihiko YOSHIMURA, Daisuke AKI & Minako ITO. (2021) SOCS, SPRED, and NR4a: Negative regulators of cytokine signaling and transcription in immune tolerance. Proceedings of the Japan Academy, Series B 97:6, pages 277-291.
Crossref
Crossref
Robert Tempest, Sonia Guarnerio, Rawan Maani, Jamie Cooper & Nicholas Peake. (2021) The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment. Cancers 13:11, pages 2788.
Crossref
Crossref
Zhi-Xiong Chong, Wan-Yong Ho, Swee-Keong Yeap, Mong-Lien Wang, Yueh Chien, Nalini Devi Verusingam & Han-Kiat Ong. (2021) Single-cell RNA sequencing in human lung cancer: Applications, challenges, and pathway towards personalized therapy. Journal of the Chinese Medical Association 84:6, pages 563-576.
Crossref
Crossref
Emre Balta, Guido H. Wabnitz & Yvonne Samstag. (2021) Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors. International Journal of Molecular Sciences 22:11, pages 5736.
Crossref
Crossref
Maria Fernanda Forni, Omar Alberto Domínguez-Amorocho, Leonardo Vinícius Monteiro de Assis, Gabriela Sarti Kinker, Maria Nathalia Moraes, Ana Maria de Lauro Castrucci & Niels Olsen Saraiva Câmara. (2021) An Immunometabolic Shift Modulates Cytotoxic Lymphocyte Activation During Melanoma Progression in TRPA1 Channel Null Mice. Frontiers in Oncology 11.
Crossref
Crossref
Mia Levite. (2021) T Cells Plead for Rejuvenation and Amplification; With the Brain’s Neurotransmitters and Neuropeptides We Can Make It Happen. Frontiers in Immunology 12.
Crossref
Crossref
Guillermo O. Rangel Rivera, Hannah M. Knochelmann, Connor J. Dwyer, Aubrey S. Smith, Megan M. Wyatt, Amalia M. Rivera-Reyes, Jessica E. Thaxton & Chrystal M. Paulos. (2021) Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Crossref
Dan Su, Gao Wu, Ran Xiong, Xiangxiang Sun, Meiqing Xu, Yide Mei & Xianning Wu. (2021) Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Mitsuhiro Akiyama, Shozo Ohtsuki, Gerald J. Berry, David H. Liang, Jörg J. Goronzy & Cornelia M. Weyand. (2021) Innate and Adaptive Immunity in Giant Cell Arteritis. Frontiers in Immunology 11.
Crossref
Crossref
Stephen Safe & Keshav Karki. (2021) The Paradoxical Roles of Orphan Nuclear Receptor 4A (NR4A) in Cancer. Molecular Cancer Research 19:2, pages 180-191.
Crossref
Crossref
Pinelopi A. Nikolopoulou, Maria A. Koufaki & Vassiliki Kostourou. (2021) The Adhesome Network: Key Components Shaping the Tumour Stroma. Cancers 13:3, pages 525.
Crossref
Crossref
Puneeth Guruprasad, Yong Gu Lee, Ki Hyun Kim & Marco Ruella. (2021) The current landscape of single-cell transcriptomics for cancer immunotherapy. Journal of Experimental Medicine 218:1.
Crossref
Crossref
Erica L. Braverman, Gail Waltz & Craig A. Byersdorfer. (2020) Immunometabolism in haematopoietic stem cell transplantation and adoptive cellular therapies. Current Opinion in Hematology 27:6, pages 353-359.
Crossref
Crossref
Andrea Moerman-Herzog, Syed J. Mehdi & Henry K. Wong. (2020) Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome. Cells 9:9, pages 1992.
Crossref
Crossref
Magalie Dosset, Elodie Lauret-Marie Joseph, Thaiz Rivera Vargas & Lionel Apetoh. (2020) Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors. Cells 9:7, pages 1727.
Crossref
Crossref
Dandan Wang, Wenxing Gu, Weiliang Chen, Jin Zhou, Le Yu, Byung Kook Kim, Xuenong Zhang & Jong Seung Kim. (2022) Advanced Nanovaccines Based on Engineering Nanomaterials for Accurately Enhanced Cancer Immunotherapy. SSRN Electronic Journal.
Crossref
Crossref
Mohamed L. Salem, sohaila M. Khalil, Ashraf Sobh & Rehab M. Elgharabawy. (2021) <i>In Vitro</i> Conditioning of Antigen-Reactive CD8 <sup>+</sup> T Cells with Toll-Like Receptor Agonists Enhances Their Expansion <i>In Vivo</i> in an Adoptive Transfer Mouse Model. SSRN Electronic Journal.
Crossref
Crossref